Bath & Body Works, Inc. (NYSE:BBWI) Stock Rated “Hold” by Sell-Side Analysts

Bath & Body Works, Inc. (NYSE:BBWI) has been given an average recommendation of “Hold” by the twenty brokerages that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, fifteen have issued a hold rating and four have given a buy rating to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $22.13.

BBWI has been the topic of several analyst reports. Morgan Stanley cut their price target on shares of Bath & Body Works from $22.00 to $20.00 and set an “equal weight” rating on the stock in a report on Thursday, August 27th. Robert W. Baird decreased their price target on Bath & Body Works from $25.00 to $23.00 and set a “neutral” rating for the company in a research report on Thursday, August 27th. BMO Capital Markets started coverage on Bath & Body Works in a research report on Tuesday, September 8th. They issued a “market perform” rating and a $20.00 price objective on the stock. Citigroup upgraded shares of Bath & Body Works from a “neutral” rating to a “buy” rating and set a $25.00 target price on the stock in a research note on Tuesday, August 18th. Finally, Deutsche Bank Aktiengesellschaft set a $22.00 target price on shares of Bath & Body Works in a research report on Thursday, August 27th.

Bath & Body Works Trading Up 0.3%

Shares of BBWI stock opened at $16.11 on Wednesday. The firm has a fifty day simple moving average of $18.55 and a two-hundred day simple moving average of $19.09. Bath & Body Works has a 12 month low of $14.27 and a 12 month high of $27.40. The firm has a market capitalization of $3.25 billion, a PE ratio of 4.20, a price-to-earnings-growth ratio of 0.81 and a beta of 1.40.

Bath & Body Works (NYSE:BBWI) last posted its earnings results on Wednesday, August 26th. The company reported $0.62 EPS for the quarter, topping the consensus estimate of $0.24 by $0.38. The company had revenue of $1.51 billion during the quarter, compared to the consensus estimate of $1.50 billion. Bath & Body Works had a net margin of 10.83% and a negative return on equity of 53.48%. The firm’s revenue for the quarter was down 2.3% on a year-over-year basis. During the same period in the previous year, the firm posted $0.30 earnings per share. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. On average, equities analysts predict that Bath & Body Works will post 2.73 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 4th. Stockholders of record on Friday, August 21st were given a dividend of $0.20 per share. The ex-dividend date was Friday, August 21st. This represents a $0.80 annualized dividend and a dividend yield of 5.0%. Bath & Body Works’s dividend payout ratio is 20.83%.

Institutional Trading of Bath & Body Works

A number of hedge funds have recently bought and sold shares of the company. BlackRock Inc. purchased a new position in shares of Bath & Body Works during the second quarter worth approximately $449,065,000. Geode Capital Management LLC grew its stake in shares of Bath & Body Works by 2.9% during the fourth quarter. Geode Capital Management LLC now owns 3,960,475 shares of the company’s stock valued at $79,542,000 after buying an additional 110,602 shares during the last quarter. Vaughan Nelson Investment Management L.P. grew its stake in shares of Bath & Body Works by 33.8% during the first quarter. Vaughan Nelson Investment Management L.P. now owns 2,852,040 shares of the company’s stock valued at $53,248,000 after buying an additional 719,795 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its holdings in shares of Bath & Body Works by 34.2% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,777,576 shares of the company’s stock worth $51,857,000 after buying an additional 707,449 shares during the period. Finally, Norges Bank purchased a new position in shares of Bath & Body Works in the fourth quarter worth about $55,504,000. Institutional investors own 95.14% of the company’s stock.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailer focused on personal care and home fragrance products. Its portfolio includes body lotions and creams, shower products, fragrances, hand soaps and sanitizers, three-wick candles, wall-plug air fresheners, and other home-fragrance items. The company markets products under the Bath & Body Works brand and regularly introduces seasonal and limited-edition collections.

The company sells its products through a network of company-operated stores, its e-commerce website, and other direct channels.